Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04693546Suspended

Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening

Role: lead

NCT02151123Withdrawn

Metabiomics Colon Cancer Clinical Research Study

Role: lead

NCT03269617Not ApplicableCompleted

PHAGE Study: Bacteriophages as Novel Prebiotics

Role: collaborator

NCT02141945Completed

Microbiome Test for the Detection of Colorectal Polyps and Cancer

Role: lead

All 4 trials loaded